Tuesday, July 21, 2026
🇺🇸 FDA

biotech · Pulmonary Disease, Chronic Obstructive · Symptomatic Neurogenic Orthostatic Hypertension · TBPH

Theravance Biopharma Ireland

Theravance Biopharma Ireland Umited

Theravance Biopharma Ireland patent portfolio — 11 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
901 Gateway Blvd., South San Francisco, CA 94080, US HQ
2014 Founded
177 Employees
Public company Type
TBPH · NYSE Ticker
Company details
Status
Public
HQ
901 Gateway Blvd., South San Francisco, CA 94080, US
Founded
2014
Employees
177
Programs
1
Drugs
7
Patents
11
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Theravance Biopharma Ireland patents

11 pharmaceutical patents indexed for Theravance Biopharma Ireland. 1 expire within 24 months.

Theravance Biopharma Ireland has 11 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

11 patents

Patent portfolio

  1. US 12285417

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12048692

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11858898

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11691948

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11484531

    Methods for treating chronic obstructive pulmonary disease

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11008289

    Crystalline freebase forms of a biphenyl compound

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10550081

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9765028

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8541451

    Crystalline freebase forms of a biphenyl compound

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7531623

    Hydrochloride salts of a glycopeptide phosphonate derivative

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7288657

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

11 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.